Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Arginase Inhibition on Endothelial Function Induced by Ischemia-reperfusion in Patients With Coronary Artery Disease

NCT02009527 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02009527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02009527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Arginase Inhibition on Endothelial Function Induced by Ischemia-reperfusion in Patients With Coronary Artery Disease
Lead sponsor
Karolinska Institutet
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2012
Completion date
September 30, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, type 2 diabetes mellitus